CoChat

In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy

Open access
Choudhury, Sourav R, Fitzpatrick, Zachary, Harris, Anne F, Maitland, Stacy A, Ferreira, Jennifer S, Zhang, Yuanfan, Ma, Shan, Sharma, Rohit B, Gray-Edwards, Heather L, Johnson, Jacob A, Johnson, Aime K, Alonso, Laura C, Punzo, Claudio, Wagner, Kathryn R, Maguire, Casey A, Kotin, Robert M, Martin, Douglas R, Sena-Esteves, Miguel · 2016 · Molecular Therapy
Cited by 113

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

Adeno-associated viral (AAV) vectors have shown promise as a platform for gene therapy of neurological disorders. Achieving global gene delivery to the central nervous system (CNS) is key for development of effective therapies for many of these diseases. Here we report the isolation of a novel CNS tropic AAV capsid, AAV-B1, after a single round of in vivo selection from an AAV capsid library. Systemic injection of AAV-B1 vector in adult mice and cat resulted in widespread gene transfer throughout the CNS with transduction of multiple neuronal subpopulations. In addition, AAV-B1 transduces muscle, β-cells, pulmonary alveoli, and retinal vasculature at high efficiency. This vector is more efficient than AAV9 for gene delivery to mouse brain, spinal cord, muscle, pancreas, and lung. Together with reduced sensitivity to neutralization by antibodies in pooled human sera, the broad transduction profile of AAV-B1 represents an important improvement over AAV9 for CNS gene therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/mt.2016.84

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 32 references

Cited by

See all 113

Metadata

Authors
Choudhury, S. R., Fitzpatrick, Z., Harris, A. F., Maitland, S. A., Ferreira, J. S., Zhang, Y., Ma, S., Sharma, R. B., Gray-Edwards, H. L., Johnson, J. A., Johnson, A. K., Alonso, L. C., Punzo, C., Wagner, K. R., Maguire, C. A., Kotin, R. M., Martin, D. R., & Sena-Esteves, M.
Venue
Molecular Therapy
Publisher
Elsevier BV
Published
2016-07
Volume
24
Issue
7
Pages
1247-1257
ISSN
1525-0016 (ISSN-L)
OpenAlex
W2409520973
Cited by
113
References
32
FWCI
10.76
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy. https://app.cochat.ai/papers/10.1038/mt.2016.84
The paper
Choudhury, S. R., Fitzpatrick, Z., Harris, A. F., Maitland, S. A., Ferreira, J. S., Zhang, Y., Ma, S., Sharma, R. B., Gray-Edwards, H. L., Johnson, J. A., Johnson, A. K., Alonso, L. C., Punzo, C., Wagner, K. R., Maguire, C. A., Kotin, R. M., Martin, D. R., & Sena-Esteves, M. (2016). In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy. Molecular Therapy. https://doi.org/10.1038/mt.2016.84

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.